Cite
HARVARD Citation
McCartney, A. et al. (2019). Prognostic role of serum thymidine kinase 1 activity in patients with hormone receptor–positive metastatic breast cancer: Analysis of the randomised phase III Evaluation of Faslodex versus Exemestane Clinical Trial (EFECT). European journal of cancer. pp. 55-66. [Online].